Relapsed/Refractory Multiple Myeloma: Hematology Journal Club

Speaker
Multiple
Category:
Myeloma

This journal club was a scientific-educational activity discussing on the convenient treatment protocols for the management of relapsed/ refractory Multiple Myeloma patients and sharing data of Carfilzomib from Moreau et al. 2018 A.R.R.O.W. Trial.

1
Once-Weekly Vs Twice-Weekly Carfilzomib Dosing in Patients with Relapsed and Refractory MM: Results if the randomized phase 3
15 minutes

Speaker: Arif Alam 

Affiliations: Division Chief of Hematology Clinic, Tawam Hospital, United Arab Emirates

 

This presentation was part of a scientific educational activity discussing on the convenient treatment protocols for the management of relapsed/ refractory Multiple Myeloma patients and sharing data of Carfilzomib from Moreau et al. 2018 A.R.R.O.W. Trial.

2
Multiple Myeloma Case Presentation
12 minutes

Speaker: Hassan Yassin

Affiliations: Internist and Clinical Hematologist, Rashid Hospital, United Arab Emirates

 

This presentation was part of a scientific educational activity discussing on the convenient treatment protocols for the management of relapsed/ refractory Multiple Myeloma patients and sharing data of Carfilzomib from Moreau et al. 2018A.R.R.O.W. Trial

3
Implememting Multiple Myeloma Clinical Trial Data Real-World practice: Tawam case Based Discussion
21 minutes

Speaker: Dr. Amar Lal 

Affiliations: Consultant Hematologist, Tawam Hospital, Al Ain, United Arab Emirates

 

This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2021.

4
Hematology Journal Club 1.0: Panel Discussion
38 minutes

Panel Discussion including Dr. Amar Lal, Dr. Faraz Khan, Dr. Hassan Yassin, and Dr. Arif Alam. 

Add to Wishlist
Enroll course
Enrolled: 4 students
Duration: 90 minutes
Presentations: 4